SEC Form 4 · accession 0001127602-17-011423
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Johst
Officer — Corporate Executive VP
Period of report
Mar 10, 2017
Accepted (ET)
Mar 13, 2017 · 3:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 10, 2017 | M | 19,750 | $37.03 | A | 201,005 | D | |
| Common Stock | Mar 10, 2017 | M | 22,150 | $36.25 | A | 223,155 | D | |
| Common Stock | Mar 10, 2017 | S | 18,064 | $89.00 | D | 205,091 | D | |
| Common Stock | Mar 10, 2017 | S | 700 | $89.01 | D | 204,391 | D | |
| Common Stock | Mar 10, 2017 | S | 300 | $89.02 | D | 204,091 | D | |
| Common Stock | Mar 10, 2017 | S | 300 | $89.06 | D | 203,791 | D | |
| Common Stock | Mar 10, 2017 | S | 6,739 | $89.07 | D | 197,052 | D | |
| Common Stock | Mar 10, 2017 | S | 1,050 | $89.08 | D | 196,002 | D | |
| Common Stock | Mar 10, 2017 | S | 800 | $89.09 | D | 195,202 | D | |
| Common Stock | Mar 10, 2017 | S | 200 | $89.10 | D | 195,002 | D | |
| Common Stock | Mar 10, 2017 | S | 7 | $89.13 | D | 194,995 | D | |
| Common Stock | Mar 10, 2017 | S | 300 | $89.14 | D | 194,695 | D | |
| Common Stock | Mar 10, 2017 | S | 400 | $89.15 | D | 194,295 | D | |
| Common Stock | Mar 10, 2017 | S | 35 | $89.17 | D | 194,260 | D | |
| Common Stock | Mar 10, 2017 | S | 400 | $89.18 | D | 193,860 | D | |
| Common Stock | Mar 10, 2017 | S | 1,173 | $89.19 | D | 192,687 | D | |
| Common Stock | Mar 10, 2017 | S | 300 | $89.20 | D | 192,387 | D | |
| Common Stock | Mar 10, 2017 | S | 275 | $89.21 | D | 192,112 | D | |
| Common Stock | Mar 10, 2017 | S | 800 | $89.22 | D | 191,312 | D | |
| Common Stock | Mar 10, 2017 | S | 100 | $89.23 | D | 191,212 | D | |
| Common Stock | Mar 10, 2017 | S | 310 | $89.24 | D | 190,902 | D | |
| Common Stock | Mar 10, 2017 | S | 301 | $89.25 | D | 190,601 | D | |
| Common Stock | Mar 10, 2017 | S | 1 | $89.26 | D | 190,600 | D | |
| Common Stock | Mar 10, 2017 | S | 950 | $89.28 | D | 189,650 | D | |
| Common Stock | Mar 10, 2017 | S | 285 | $89.29 | D | 189,365 | D | |
| Common Stock | Mar 10, 2017 | S | 301 | $89.30 | D | 189,064 | D | |
| Common Stock | Mar 10, 2017 | S | 1 | $89.31 | D | 189,063 | D | |
| Common Stock | Mar 10, 2017 | S | 1 | $89.32 | D | 189,062 | D | |
| Common Stock | Mar 10, 2017 | S | 400 | $89.33 | D | 188,662 | D | |
| Common Stock | Mar 10, 2017 | S | 100 | $89.34 | D | 188,562 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $37.03 | Mar 10, 2017 | M | 19,750 | D | Feb 25, 2012 | Feb 25, 2018 | Common Stock | 19,750 | 0 | D |
| Stock Options (Right to Buy) | $36.25 | Mar 10, 2017 | M | 22,150 | D | Feb 24, 2013 | Feb 24, 2019 | Common Stock | 22,150 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.